Denial Prevention Is the New Revenue Growth Strategy in 2026

For years, healthcare organizations focused on volume-based growth—more patients, more procedures, more claims. In 2026, that strategy is failing.

Payers aren’t reducing reimbursements quietly—they’re denying claims aggressively. Practices that continue to rely on post-denial appeals are discovering a harsh reality:
Denied revenue is often never recovered.